One Drug or Two for Hepatitis B in HIV-Coinfected Patients?
In HIV-HBV coinfected individuals, initial treatment with tenofovir + 3TC and sequential monotherapy with tenofovir after 3TC failure produced similar viral suppression rates, at least in the intermediate term.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Sign In
Sign Up
Print subscribers
Activate your free online account for full access to all site content and features.
Other visitors
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)